| Literature DB >> 27354268 |
Sophia E Maharry1, Christopher J Walker1, Sandya Liyanarachchi1, Sujay Mehta1, Mitra Patel1, Maryam A Bainazar1, Xiaomeng Huang1, Malori A Lankenau1, Kevin W Hoag1, Parvathi Ranganathan1, Ramiro Garzon1, James S Blachly1, Denis C Guttridge1, Clara D Bloomfield1, Albert de la Chapelle1, Ann-Kathrin Eisfeld2.
Abstract
UNLABELLED: Chromosomal aberrations and multiple genome-wide association studies (GWAS) have established a major hematopoietic quantitative trait locus in chromosome 6q23.3. The locus comprises an active enhancer region, in which some of the associated SNPs alter transcription factor binding. We now identify miR-3662 as a new functional driver contributing to the associated phenotypes. The GWAS SNPs are strongly associated with higher miR-3662 expression. Genome editing of rs66650371, a three-base-pair deletion, suggests a functional link between the SNP genotype and the abundance of miR-3662. Increasing miR-3662's abundance increases colony formation in hematopoietic progenitor cells, particularly the erythroid lineage. In contrast, miR-3662 is not expressed in acute myeloid leukemia cells, and its overexpression has potent antileukemic effects in vitro and in vivo Mechanistically, miR-3662 directly targets NF-κB-mediated transcription. Thus, miR-3662 is a new player of the hematopoietic 6q23.3 locus. SIGNIFICANCE: The characterization of miR-3662 has identified a new actor in the prominent hematopoietic quantitative trait locus in chromosome 6q23.3. The mechanistic insights into miR-3662's function may reveal novel or only partially known pathways for normal and malignant hematopoietic cell proliferation. Cancer Discov; 6(9); 1036-51. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 932. ©2016 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27354268 PMCID: PMC5168803 DOI: 10.1158/2159-8290.CD-16-0023
Source DB: PubMed Journal: Cancer Discov ISSN: 2159-8274 Impact factor: 39.397